Please wait while the formulary information is being retrieved.
LYSTEDA (TRANEXAMIC ACID)
- Menorrhagia
650 mg tablet
- 2 tablets (1,300 mg) by oral route 3 times per day during menses
650 mg tablet
- 2 tablets (1,300 mg) by oral route 3 times per day during menses
Menorrhagia
- 2 tablets (1,300 mg) by oral route 3 times per day during menses
- 2 tablets (1,300 mg) by oral route 3 times per day during mensesfor 5 days
- Activella
- Alora
- Altavera (28)
- Alyacen 1/35 (28)
- Alyacen 7/7/7 (28)
- Amethia
- Amethia Lo
- Amethyst
- Angeliq
- anti-inhibitor coagulant cmplx
- Apri
- Aranelle (28)
- Aubra
- Aviane
- Azurette (28)
- Balziva (28)
- Bebulin
- Bebulin Vh
- Beyaz
- Brevicon (28)
- Briellyn
- Camrese
- Camrese Lo
- Caziant (28)
- Chateal
- Climara
- Climara Pro
- coagulation factor IX (recomb)
- Combipatch
- conj estrogens-bazedoxifene
- Cryselle (28)
- Cyclafem 1/35 (28)
- Cyclafem 7/7/7 (28)
- Cyclessa (28)
- Dasetta 1/35 (28)
- Dasetta 7/7/7 (28)
- Daysee
- Delestrogen
- Depo-estradiol
- desog-e.estradiol/e.estradiol
- Desogen
- desogestrel-ethinyl estradiol
- Divigel
- drospirenone-e.estradiol-lm.FA
- drospirenone-estradiol
- drospirenone-ethinyl estradiol
- Duavee
- Elestrin
- Elinest
- Emoquette
- Enpresse
- Enskyce
- Estarylla
- Estrace
- estradiol
- estradiol cypionate
- Estradiol Transdermal Patch
- estradiol valerate
- estradiol valerate-dienogest
- estradiol-levonorgestrel
- estradiol-norethindrone acet
- estradiol-norgestimate
- Estrasorb
- Estrogel
- Estrostep Fe-28
- ethynodiol diac-eth estradiol
- etonogestrel-ethinyl estradiol
- Evamist
- factor IX complex
- Falmina (28)
- Feiba Nf
- Feiba Vh Immuno
- Femcon Fe
- Femhrt Low Dose
- Generess Fe
- Gianvi (28)
- Gildagia
- Gildess
- Gildess Fe
- human prothrombin complex(PCC)
- Introvale
- Jinteli
- Jolessa
- Junel 1.5/30 (21)
- Junel 1/20 (21)
- Junel Fe 1.5/30 (28)
- Junel Fe 1/20 (28)
- Kariva (28)
- Kcentra
- Kelnor 1/35 (28)
- Kurvelo
- L norgest&E estradiol-E estrad
- Larin 1/20 (21)
- Larin Fe
- Leena 28
- Lessina
- Levonest (28)
- levonorg-eth estrad triphasic
- levonorgestrel-ethinyl estrad
- Levora 0.15/30 (28)
- Levora-28
- Lo Loestrin Fe
- Loestrin 1.5/30 (21)
- Loestrin 1/20 (21)
- Loestrin Fe 1.5/30 (28)
- Loestrin Fe 1/20 (28)
- Lomedia 24 Fe
- Loryna (28)
- Loseasonique
- Low-ogestrel (28)
- Lutera (28)
- Marlissa
- Menostar
- Microgestin 1.5/30 (21)
- Microgestin 1/20 (21)
- Microgestin Fe 1.5/30 (28)
- Microgestin Fe 1/20 (28)
- Mimvey
- Minastrin 24 Fe
- Minivelle
- Mircette (28)
- Modicon (28)
- Mono-linyah
- Mononessa (28)
- Myzilra
- Natazia
- Necon 0.5/35 (28)
- Necon 1/35 (28)
- Necon 1/50 (28)
- Necon 10/11 (28)
- Necon 7/7/7 (28)
- norelgestrom-ethinyl estradiol
- noreth-ethinyl estradiol-iron
- norethin-e.estradiol triphasic
- norethin-eth estrad biphasic
- norethindrone ac-eth estradiol
- norethindrone-e.estradiol-iron
- norethindrone-ethin estradiol
- norethindrone-mestranol
- norgestimate-ethinyl estradiol
- norgestrel-ethinyl estradiol
- Norinyl 1+35 (28)
- Norinyl 1+50 (28)
- Nortrel 0.5/35 (28)
- Nortrel 1/35 (21)
- Nortrel 1/35 (28)
- Nortrel 7/7/7 (28)
- Nuvaring
- Ocella
- Ogestrel (28)
- Orsythia
- Ortho Evra
- Ortho Tri-cyclen (28)
- Ortho Tri-cyclen Lo (28)
- Ortho-cept (28)
- Ortho-cyclen (28)
- Ortho-novum 1/35 (28)
- Ortho-novum 7/7/7 (28)
- Ovcon-35 (28)
- Philith
- Pimtrea (28)
- Pirmella
- Portia
- Prefest
- Previfem
- Quartette
- Quasense
- Reclipsen (28)
- Rixubis
- Safyral
- Seasonique
- Sprintec (28)
- Sronyx
- Syeda
- Tilia Fe
- Tri-estarylla
- Tri-legest Fe
- Tri-linyah
- Tri-norinyl (28)
- Tri-previfem (28)
- Tri-sprintec (28)
- Trinessa (28)
- Trivora (28)
- Velivet Triphasic Regimen (28)
- Vestura (28)
- Viorele (28)
- Vivelle-dot
- Vyfemla (28)
- Wera (28)
- Wymzya Fe
- Yasmin (28)
- Yaz 28
- Zarah
- Zenchent (28)
- Zenchent Fe
- Zeosa
- Zovia 1/35E (28)
- Zovia 1/50E (28)
Contraindicated
- tretinoin (chemotherapy)
Severe
Moderate
- None
- None
Contraindicated
- Acute myocardial infarction
- Acute pulmonary thromboembolism
- Cerebral edema
- Cerebral thrombosis
- Cerebrovascular accident
- Deep venous thrombosis
- Renal disease with moderate to severe impairment
- Retinal thrombosis
- Subarachnoid intracranial hemorrhage
- Thromboembolic disorder
- Thrombophilia
- Thrombotic disorder
- Valvular heart disease
Severe
Moderate
- Ligneous conjunctivitis
LYSTEDA (TRANEXAMIC ACID)
- Menorrhagia
- Abdominal pain with cramps
- Back pain
- Cramps
- Headache disorder
- Migraine
- Myalgias
- Anemia
- Arthralgias
- Diarrhea
- Nausea
- Sinusitis
- Vomiting
More Frequent
Severe
Less Severe
- None
- Fatigue
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Anaphylaxis
- Cerebrovascular accident
- Ligneous conjunctivitis
- Renal infarction
- Retinal vascular occlusion
- Thromboembolic disorder
- Thrombotic disorder
- Venous thrombosis
- Visual changes
Less Severe
- Acquired chromatopsia
- Dizziness
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
Tranexamic Acid (Oral)
Not for use pre-menarche.
- 1 Day – 13 Years
- Not for use pre-menarche.
Tranexamic Acid
- Severity Level:
B
- Additional Notes: Crosses placenta; insufficient data available
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Tranexamic Acid
Limited data suggest low amount excreted;W/no known adverse effect in infant
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Excreted | Not known; no or inclusive data | Limited data suggest low amount excreted;W/no known adverse effect in infant |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Menorrhagia | |
| N92.0 | Excessive and frequent menstruation with regular cycle |
| N92.1 | Excessive and frequent menstruation with irregular cycle |
| N92.2 | Excessive menstruation at puberty |
| N92.4 | Excessive bleeding in the premenopausal period |
| N92.5 | Other specified irregular menstruation |
| N92.6 | Irregular menstruation, unspecified |
| N93.8 | Other specified abnormal uterine and vaginal bleeding |
| N93.9 | Abnormal uterine and vaginal bleeding, unspecified |
| 0-9 | A-Z |
|---|---|
| N92.0 | Excessive and frequent menstruation with regular cycle |
| N92.1 | Excessive and frequent menstruation with irregular cycle |
| N92.2 | Excessive menstruation at puberty |
| N92.4 | Excessive bleeding in the premenopausal period |
| N92.5 | Other specified irregular menstruation |
| N92.6 | Irregular menstruation, unspecified |
| N93.8 | Other specified abnormal uterine and vaginal bleeding |
| N93.9 | Abnormal uterine and vaginal bleeding, unspecified |
Formulary Reference Tool